Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer
- DOI
- 10.1001/jamanetworkopen.2025.29225
- Published
- 2025-09-10
- Container
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamanetworkopen.2025.29225,
title = {Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer},
author = {Adrien Rousseau and Noémie Simon-Tillaux and Stefan Michiels and Lisa Derosa and Ariane Laparra and David Planchard and Jordi Remon and Fabrice Barlesi and Pernelle Lavaud and Maxime Frelaut and Claudia Parisi and Anas Gazzah and Benjamin Besse and Stéphanie Foulon},
year = {2025},
journal = {JAMA Network Open},
doi = {10.1001/jamanetworkopen.2025.29225},
url = {https://doi.org/10.1001/jamanetworkopen.2025.29225}
}RIS
TY - JOUR TI - Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer AU - Adrien Rousseau AU - Noémie Simon-Tillaux AU - Stefan Michiels AU - Lisa Derosa AU - Ariane Laparra AU - David Planchard AU - Jordi Remon AU - Fabrice Barlesi AU - Pernelle Lavaud AU - Maxime Frelaut AU - Claudia Parisi AU - Anas Gazzah AU - Benjamin Besse AU - Stéphanie Foulon PY - 2025 JO - JAMA Network Open DO - 10.1001/jamanetworkopen.2025.29225 UR - https://doi.org/10.1001/jamanetworkopen.2025.29225 ER -
APA
Rousseau, A., Simon-Tillaux, N., Michiels, S., Derosa, L., Laparra, A., Planchard, D., Remon, J., Barlesi, F., Lavaud, P., Frelaut, M., Parisi, C., Gazzah, A., Besse, B., & Foulon, S. (2025). Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.29225
Source records
- crossref · retrieved 2026-09-25T07:49:31.430Z